CR MEDICAL (01515) has officially announced a significant leadership change, appointing Mr. Yu Changjiu as its new Chief Financial Officer.
According to a company filing, Mr. Yu's appointment became effective on August 20, 2026, marking a strategic addition to the executive management team as the company continues to strengthen its financial operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.